Charles Younes: What’s next for UK equities?
‘Despite the general gloom, UK equities are often quick to turnaround in the aftermath of a crisis’
Equities
-
-
Acacia sells off more UK science stocks from Neil Woodford’s old fund
4D Pharma is currently trading at a fraction of the price it commanded during Woodford Equity Income’s heyday
-
What segments of the healthcare sector are most resilient amid the Covid-19 outbreak?
Financial benefits for any company that discovers a Covid-19 vaccine splits analyst opinion
-
Charles Montanaro commits to five more years on investment trust and bulks out team
Montanaro UK Smaller Companies outperforms benchmark by 17.4%
-
Acacia Research shrugs off ‘silly’ criticism after swiftly flipping Woodford assets
US buyer describes the low purchase price of Midatech as ‘a function of the tax and accounting treatment’
-
Alexander Darwall trust rebounds as large Wirecard holding is chucked
European Opportunities Investment Trust had a 10% weighting in the troubled payments business
-
Link accused of letting further middleman chip into Woodford investor savings
ACD transferred eight stakes valued at £150m to Acacia Research last week
-
Alexander Darwall trust falls 11% as chunky Wirecard weighting plummets
German payments business had once represented 17% of the European Opportunities Investment Trust
-
Jupiter raids Columbia Threadneedle once again to build out European team
Phil Macartney will join his former colleagues Mark Nichols and Mark Heslop later this year
-
Invesco unveils fewer punchy bets in first factsheets since Mark Barnett’s exit
Ciaran Mallon and James Goldstone splice financials and introduce a European stock to the top-10 holdings
-
SJP director claims new ESG framework would have filtered out Woodford
Rob Gardner says Woodford was ‘one of the worst-rated managers’ on SJP’s internal ratings system
-
European investors hit the brakes on Japanese equity funds
European domiciled Japanese equity funds shed £8.3bn between January and May